Fresenius | Tillgångar



Assets Ändra Datum
Akzo Nobel EUR 14.25B 1.1B 2024-12
Alcon AG USD 30.35B 15M 2024-12
AstraZeneca USD 104.04B 887M 2024-12
BASF EUR 79.36B 3.09B 2024-09
Bayer EUR 110.85B 3.9B 2024-12
Beiersdorf EUR 13.01B 440M 2024-12
DaVita Healthcare Partners USD 17.29B 218.47M 2024-12
Demant DKK 32.45B 60M 2024-12
E.ON EUR 108.58B 429M 2024-09
Essilor EUR 64.26B 2.77B 2024-12
Fresenius EUR 43.55B 1.18B 2024-12
Fresenius Medical Care EUR 33.57B 1.06B 2024-12
Getinge SEK 63.92B 4.3B 2024-12
Givaudan CHF 12.18B 1.05B 2024-06
GlaxoSmithKline GBP 59.46B 1.41B 2024-12
GN Store Nord DKK 21.68B 7.9B 2024-12
GRIFOLS EUR 21.41B 1.12B 2024-12
Hikma Pharmaceutical USD 4.85B 167M 2024-06
Lonza CHF 19.73B 1.85B 2024-12
Merck EUR 50.14B 267M 2024-09
Novartis USD 102.25B 1.28B 2024-12
Philips EUR 28.98B 498M 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12
RWE EUR 98.57B 992M 2024-09
Sanofi 129.76B 3.29B 2024-06
Smith & Nephew USD 10.35B 188M 2024-12



Fresenius Tillgångar - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2025.